US-COHORT ANALYSIS: FIVE-YEAR OUTCOMES OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND LUNG CANCER PRESCRIBED ANTIFIBROTICSGlenn Eiger, Jose Manuel Martinez Manzano, RAUL LEGUIZAMON et al.|CHEST Journal|2025Cited by 0
DOES A SINGLE HIGH BLOOD MONOCYTE COUNT IN PATIENTS WITH CORONARY ARTERY DISEASE CONFER A HIGHER RISK FOR INTERSTITIAL LUNG DISEASE AND PULMONARY FIBROSIS?Zurab Azmaiparashvili, John Malin, Justin Riley Lam et al.|CHEST Journal|2025Cited by 0
ASSOCIATION OF RECURRENT PNEUMONIA EVENTS WITH INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITISZurab Azmaiparashvili, Jose Manuel Martinez Manzano, RAUL LEGUIZAMON et al.|CHEST Journal|2025Cited by 0
CHARACTERISTICS AND CLINICAL OUTCOMES OF EOSINOPHILIC BRONCHIECTASIS PATIENTS WITHOUT ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING INHALED CORTICOSTEROIDSEsteban Kosak Lopez, Sadia Benzaquen, Jose Manuel Martinez Manzano et al.|CHEST Journal|2025Cited by 0
Association of ICD-10-Coded Pneumonia Events with Interstitial Lung Disease Outcomes in Patients with Rheumatoid Arthritis: A Large Database Retrospective CohortEduardo Lopez, Shahrzad Abdollahi, Luis Rodriguez Donís et al.|Advances in respiratory medicine|2026Cited by 0